Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2004
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
10822 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 33 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591098 | ||
| 003 | DE-604 | ||
| 005 | 20100128 | ||
| 007 | t | ||
| 008 | 050106s2004 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)56973324 | ||
| 035 | |a (DE-599)BVBBV023591098 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1 | |
| 245 | 1 | 0 | |a Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |c Ernst R. Berndt ... |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2004 | |
| 300 | |a 33 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 10822 | |
| 610 | 2 | 4 | |a United States. |b Food and Drug Administration |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drug Approval |z United States | |
| 650 | 4 | |a Drug Prescriptions |z United States | |
| 650 | 4 | |a Drugs |x Prices |x Law and legislation | |
| 650 | 4 | |a Legislation, Drug |x economics |z United States | |
| 650 | 4 | |a Pharmaceutical industry |x Law and legislation | |
| 650 | 4 | |a Prescription pricing |x Law and legislation | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Berndt, Ernst R. |e Sonstige |0 (DE-588)128550783 |4 oth | |
| 700 | 1 | |a Gottschalk, Adrian H. B. |e Sonstige |0 (DE-588)129709026 |4 oth | |
| 700 | 1 | |a Philipson, Tomas J. |e Sonstige |0 (DE-588)128733101 |4 oth | |
| 700 | 1 | |a Strobeck, Matthew W. |d 1972- |e Sonstige |0 (DE-588)130562637 |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 10822 |w (DE-604)BV002801238 |9 10822 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w10822.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016906428 | ||
Datensatz im Suchindex
| _version_ | 1804138248057913344 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author_GND | (DE-588)128550783 (DE-588)129709026 (DE-588)128733101 (DE-588)130562637 |
| building | Verbundindex |
| bvnumber | BV023591098 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)56973324 (DE-599)BVBBV023591098 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01841nam a2200457zcb4500</leader><controlfield tag="001">BV023591098</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100128 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050106s2004 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)56973324</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591098</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process</subfield><subfield code="c">Ernst R. Berndt ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">33 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">10822</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Prescriptions</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="x">Law and legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Law and legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription pricing</subfield><subfield code="x">Law and legislation</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berndt, Ernst R.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)128550783</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gottschalk, Adrian H. B.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)129709026</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Philipson, Tomas J.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)128733101</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strobeck, Matthew W.</subfield><subfield code="d">1972-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)130562637</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">10822</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">10822</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w10822.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906428</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023591098 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:27Z |
| indexdate | 2024-07-09T21:25:10Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906428 |
| oclc_num | 56973324 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 33 S. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process Ernst R. Berndt ... Cambridge, Mass. National Bureau of Economic Research 2004 33 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 10822 United States. Food and Drug Administration Recht Drug Approval United States Drug Prescriptions United States Drugs Prices Law and legislation Legislation, Drug economics United States Pharmaceutical industry Law and legislation Prescription pricing Law and legislation USA Berndt, Ernst R. Sonstige (DE-588)128550783 oth Gottschalk, Adrian H. B. Sonstige (DE-588)129709026 oth Philipson, Tomas J. Sonstige (DE-588)128733101 oth Strobeck, Matthew W. 1972- Sonstige (DE-588)130562637 oth Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 10822 (DE-604)BV002801238 10822 http://papers.nber.org/papers/w10822.pdf kostenfrei Volltext |
| spellingShingle | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series United States. Food and Drug Administration Recht Drug Approval United States Drug Prescriptions United States Drugs Prices Law and legislation Legislation, Drug economics United States Pharmaceutical industry Law and legislation Prescription pricing Law and legislation |
| title | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |
| title_auth | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |
| title_exact_search | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |
| title_exact_search_txtP | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |
| title_full | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process Ernst R. Berndt ... |
| title_fullStr | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process Ernst R. Berndt ... |
| title_full_unstemmed | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process Ernst R. Berndt ... |
| title_short | Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process |
| title_sort | assessing the impacts of the prescription drug user fee acts pdufa on the fda approval process |
| topic | United States. Food and Drug Administration Recht Drug Approval United States Drug Prescriptions United States Drugs Prices Law and legislation Legislation, Drug economics United States Pharmaceutical industry Law and legislation Prescription pricing Law and legislation |
| topic_facet | United States. Food and Drug Administration Recht Drug Approval United States Drug Prescriptions United States Drugs Prices Law and legislation Legislation, Drug economics United States Pharmaceutical industry Law and legislation Prescription pricing Law and legislation USA |
| url | http://papers.nber.org/papers/w10822.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT berndternstr assessingtheimpactsoftheprescriptiondruguserfeeactspdufaonthefdaapprovalprocess AT gottschalkadrianhb assessingtheimpactsoftheprescriptiondruguserfeeactspdufaonthefdaapprovalprocess AT philipsontomasj assessingtheimpactsoftheprescriptiondruguserfeeactspdufaonthefdaapprovalprocess AT strobeckmattheww assessingtheimpactsoftheprescriptiondruguserfeeactspdufaonthefdaapprovalprocess |